The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules

Kirill Gorshkov(National Center for Advancing Translational Sciences), Wei Zheng(Liaoning Cancer Hospital & Institute), Catherine Z. Chen(National Institutes of Health), Manisha Pradhan(National Institutes of Health), Khalida Shamim(National Institutes of Health), Matthew D. Hall(National Institutes of Health), Juan Carlos de la Torre(Scripps Research Institute), Robert Bostwick(Southern Research Institute), Zina Itkin(National Institutes of Health), Wenwei Huang(National Institutes of Health), Carleen Klumpp‐Thomas(National Institutes of Health), Lynn Rasmussen, Sam Michael(National Institutes of Health), Anton Simeonov(National Institutes of Health), Mason A. Wolak(United States Naval Research Laboratory), Kimihiro Susumu(Sotera Defense Solutions (United States)), Wei Zhu(Guangzhou University of Chinese Medicine), Mark J. Henderson(National Center for Advancing Translational Sciences), Bruce Nguyen Tran(National Center for Advancing Translational Sciences), Min Shen(Kaili University), Miao Xu(National Institutes of Health), Xin Hu(Discovery Institute), Yu-Shan Cheng(National Institutes of Health), Eunkeu Oh(Sotera Defense Solutions (United States)), Paul Shinn(National Institutes of Health), Donald C. Lo(Center for Translational Molecular Medicine)
ACS Infectious Diseases
December 21, 2020
Cited by 93


Related Papers